Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass. Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology…